Build a sustainable
340B Program
Are you concerned about staying compliant with 340B Audit requirements? Afraid of missing hidden savings, facing costly penalties, or compromising patient access? Compass340B understands these challenges. Our FREE 340B compliance assessment will help you maximize patient access, maintain compliance, and boost savings. Our experts will review your program, identify compliance risks, and enhance your process efficiency to improve patient experience and reduce operating costs. Call us now or fill out the form below to schedule your FREE assessment.
01. Assess
Our process always begins with understanding the current state of your system by conducting audits of policies, processes, software and reports to understand the full compliance picture.
02. Implement
We design bespoke strategies and processes for your program, helping you deploy actionable tools for compliance improvement and 340B setup.
03. Monitor
We offer continued support to ensure your program is seeing desired results. We implement ongoing support like post-deployment audits, before/after metrics, and change logging.
Service
Providing the best insight with decades of 340B experience and networks.
Experience
Understanding what it takes to succeed in the industry, and making accessible and achievable for our clients.
Relationships
Prioritizing building partnerships with communication and shared trust.
Assessment
Consultant reviews your current 340B program policies and procedures, vendors, auditable records and supporting documentation to ensure they are in alignment with the PHSA/HRSA OPA 340B program requirements.
hear From Our Clients
Trusted by healthcare systems and their leaders
“I have worked with HMG on and off for 3 + years. Whether the question is simple or esoteric, their team has always been the one with the answer or the know-how on how to find it."
Dir. of Pharmacy, NM
"They are very knowledgeable in the 340B space and compliance area. I have used their services to conduct third party audits on our 340B program...including clinical administering of 340B drugs to our patients along with tracking tools. "
